NCT07045753

Brief Summary

A Prospective Follow-up Assessment in Bad Segeberg for Patients with severe MR undergoing M-TEER

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
81mo left

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Jan 2011Dec 2032

Study Start

First participant enrolled

January 1, 2011

Completed
14.5 years until next milestone

First Submitted

Initial submission to the registry

June 22, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 1, 2025

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

20 years

First QC Date

June 22, 2025

Last Update Submit

June 22, 2025

Conditions

Mitral Regurgitation (MR)

Keywords

M TEERMitral Clip

Outcome Measures

Primary Outcomes (1)

  • Rate of in-hospital and long-term cardiovascular adverse events in percent

    Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death, heart failure, rehospitalization)

    2 years

Study Arms (1)

Patients of severe MR undergoing M-TEER

Patients with severe mitral regurgitation undergoing transcatheter edge to edge repair (M-TEER)

Device: Transcatheter edge to edge repair

Interventions

Transcatheter edge to edge repairDEVICE

mitral valve transcatheter edge-to-edge repair

Also known as: M TEER, Mitral Clip
Patients of severe MR undergoing M-TEER

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with severe MR undergoing M-TEER

You may qualify if:

  • Patients with severe MR undergoing M-TEER

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herzzentrum Segeberger Kliniken GmbH

Bad Segeberg, Schleswig-Holstein, 23795, Germany

RECRUITING

MeSH Terms

Conditions

Mitral Valve Insufficiency

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Study Officials

  • Holger Nef, Prof., MD

    Herzzentrum Segeberger Kliniken GmbH

    STUDY DIRECTOR

Central Study Contacts

Arief Kurniadi, MD

CONTACT

+4945512802arief.kurniadi@segebergerkliniken.de

Stephan Fichtlscherer, Prof., MD

CONTACT

+4945512802Stephan.fichtlscherer@segebergerkliniken.de

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2025

First Posted

July 1, 2025

Study Start

January 1, 2011

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2032

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations

DE(1)